Patenting of Antibodies in Europe

In this report, our legal and regulatory analysts provide a background on patenting antibodies at the European Patent Office (EPO) and its member states. We then synthesize and analyze multiple case studies involving the validity and potential infringement of broad, functionally defined antibody patents.

IPD’s European Life-Cycle Insights coverage includes periodic macro reports to help our subscribers identify read-through from one case to another and to understand larger issues at play.

Content on this site is proprietary to IPD Analytics. By receiving this sample you are agreeing to refrain from any unauthorized use, including uploading or inputting into AI tools or large language models for any purpose, is strictly prohibited.